Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study
Fink, DL, Collins, S, Barret, R, Pollara, G, Marks, M and Logan, S.
2019.
Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study.
[Online].
PLOS One.
Available from:
https://doi.org/10.1371/journal.pone.0223130
Fink, DL, Collins, S, Barret, R, Pollara, G, Marks, M and Logan, S.
Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study
[Internet].
PLOS One;
2019.
Available from:
https://doi.org/10.1371/journal.pone.0223130
Fink, DL, Collins, S, Barret, R, Pollara, G, Marks, M and Logan, S
(2019).
Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study.
[Data Collection].
PLOS One.
https://doi.org/10.1371/journal.pone.0223130
Description
The incidence of multi-drug resistant ESBL-associated urinary tract infections (UTIs) is increasing globally. Patients with abnormal renal tract anatomy and other co-morbidities are at increased risk of complicated UTI and ESBL-associated infections. The duration and safety of OPAT for this cohort of patients is unknown.